Retinal and choroidal efficacy of switching treatment to faricimab in recalcitrant neovascular age related macular degeneration

Abstract Aim of this study was to evaluate the efficacy of switching treatment to faricimab in neovascular age-related macular degeneration (nAMD) from other anti-VEGF agents. Fifty-eight eyes of fifty-one patients with nAMD and a full upload series of four faricimab injections were included. Demogr...

Полное описание

Библиографические подробности
Главные авторы: Franziska Eckardt, Anna Lorger, Michael Hafner, Julian Elias Klaas, Benedikt Schworm, Thomas Christian Kreutzer, Siegfried Georg Priglinger, Jakob Siedlecki
Формат: Статья
Язык:English
Опубликовано: Nature Portfolio 2024-04-01
Серии:Scientific Reports
Online-ссылка:https://doi.org/10.1038/s41598-024-59632-0